NCT06777160 Predicting Bone Cement Implantation Syndrome Using Artificial Intelligence Methods
| NCT ID | NCT06777160 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ataturk University |
| Condition | Bone Cement Implantation Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-09-08 |
| Primary Completion | 2025-03-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2024-09-08 with a primary completion date of 2025-03-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to predict the development of bone cement syndrome, which may develop due to polymethylmethacrylate cement used to adhere the prosthesis to the bone in arthroplasty surgeries, which may cause intraoperative and postoperative mortality and morbidity, using artificial intelligence methods and to provide a sustainable life comfort to patients in the postoperative period with the standardization predicted in the long term.
Eligibility Criteria
Inclusion Criteria: 1. Total knee arthrplasties 2. Partial hip arthrplasty using cement 3. Total hip arthrplasty using cement 4. Patients ≥18 years old. Exclusion Criteria: Patients who do not want to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06777160 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bone Cement Implantation Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06777160 currently recruiting?
Yes, NCT06777160 is actively recruiting participants. Contact the research team at mcagatayengin@hotmail.com for enrollment information.
Where is the NCT06777160 trial being conducted?
This trial is being conducted at Erzurum, Turkey (Türkiye).
Who is sponsoring the NCT06777160 clinical trial?
NCT06777160 is sponsored by Ataturk University. The trial plans to enroll 250 participants.